CARM CARISMA THERAP

OTC
$0.00

CARISMA THERAP (CARM) is expected to report earnings on August 6, 2026, before the market open.

Earnings Date
Aug 6
Thursday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About CARISMA THERAP

Carisma Therapeutics Inc. is a late-stage clinical company which focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's advanced product candidate includes Vicineum(TM). Carisma Therapeutics Inc., formerly known as Sesen Bio Inc., is based in CAMBRIDGE, Mass.

Charts powered in part by Lightweight Charts™ by TradingView.